New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Stevanato Group S.p.A.
STVN
Shape
US Flag

NYSE

5B

Medical - Instruments & Supplies

Next Earning date - 29 Oct 2024

5B

Medical - Instruments & Supplies

Next Earning date - 29 Oct 2024

19.66USD
Shape-0.34 ( -1.70%)
favorite-chart

Relative Strenght

3
favorite-chart

Volume Buzz

34%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

45%

Quote Panel

Shape
Updated October 4, 2024
1W -1.70 % 1M -8.09 % 3M 6.10 % 1Y -36.87 %

Key Metrics

Shape
  • Market Cap

    5.36B


  • Shares Outstanding

    272.68M


  • Share in Float

    48.44M


  • Dividende

    0.06


  • Earning Date

    29 Oct 2024


  • Price Target

    19.66


  • Average Volume

    538931


  • Beta

    0.575


  • Range

    16.56-35.56


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.stevanatogroup.com


  • Sector

    Healthcare


Fundamentals

Shape

38.68x

P/E Ratio

4.57x

P/S Ratio

3.73x

P/B Ratio

0.2

Debt/Equity

11.3%

Net Margin

$0.5

EPS

How STVN compares to sector?

P/E Ratio

Relative Strength

Shape

STVN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1B

Shape356%

2025-Revenue

$0.54

Shape616%

2025-EPS

$268M

Shape489%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Stephens

initialise

Previous: Not converted

2023-09-26

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+17%

0.14
vs 0.12

Q4.22

arrow
arrow

+38%

0.18
vs 0.13

Q1.23

arrow
arrow

N/A

0.11
vs 0.11

Q2.23

arrow
arrow

+17%

0.14
vs 0.12

Q3.23

arrow
arrow

+7%

0.15
vs 0.14

Q4.23

arrow
arrow

N/A

0.18
vs 0.18

Q1.24

arrow
arrow

-27%

0.08
vs 0.11

Q2.24

arrow
arrow

-30%

0.1
vs 0.14

Q3.24

arrow
arrow

-6%

0.14
vs 0.15

Q4.24

arrow
arrow

+15%

0.21
vs 0.18

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+14%

245.3M  vs 214.5M

Q4.22

arrow
arrow

+26%

292.1M  vs 232.6M

Q1.23

arrow
arrow

+12%

238M  vs 212.1M

Q2.23

arrow
arrow

+9%

255.3M  vs 234.2M

Q3.23

arrow
arrow

+11%

271.4M  vs 245.3M

Q4.23

arrow
arrow

+7%

312.4M  vs 292.1M

Q1.24

arrow
arrow

0%

237.4M  vs 238M

Q2.24

arrow
arrow

+2%

260.9M  vs 255.3M

Q3.24

arrow
arrow

+13%

305.5M  vs 271.4M

Q4.24

arrow
arrow

+15%

358.5M  vs 312.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+4%

0.04
vs 0.03

Q4.22

arrow
arrow

+5%

0.05
vs 0.04

Q1.23

arrow
arrow

+3%

0.03
vs 0.05

Q2.23

arrow
arrow

+3%

0.03
vs 0.03

Q3.23

arrow
arrow

+3%

0.03
vs 0.03

Q4.23

arrow
arrow

+4%

0.04
vs 0.03

Q1.24

arrow
arrow

+1%

0.01
vs 0.04

Q2.24

arrow
arrow

+2%

0.02
vs 0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

86

86
vs 71

21%

Q4.22

arrow
arrow

108

108
vs 86

26%

Q1.23

arrow
arrow

108

108
vs 108

NA

Q2.23

arrow
arrow

121

121
vs 108

12%

Q3.23

arrow
arrow

127

127
vs 121

5%

Q4.23

arrow
arrow

136

136
vs 127

7%

Q1.24

arrow
arrow

149

149
vs 136

10%

Q2.24

arrow
arrow

131

131
vs 149

-12%

Earnings Growth

Latest News